| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |